Orthofix exec granted stock options and RSUs

Orthofix Medical Inc. executive Patrick Fisher, President, Global Limb Recon, reported equity awards on March 3, 2026.

Rhea-AI Filing Summary

Orthofix Medical Inc. executive Patrick Fisher, President, Global Limb Recon, reported equity awards on March 3, 2026. He received 50,101 employee stock options with an exercise right to buy Orthofix common shares and a grant of 21,105 shares of common stock as restricted stock units at no cash cost.

The restricted stock units vest in equal one-third installments on the first, second, and third anniversaries of the grant date, and the options vest on the same three-year schedule. Following these grants, Fisher directly owns 52,169 shares of common stock, which include previously reported restricted stock units and 948 shares acquired under Orthofix’s Stock Purchase Plan, and holds 50,101 stock options.

Insider Trade Summary

Grant/Award: 71,206 shares

Grant/Award 2 txns

Insider Fisher Patrick

Role President, Global Limb Recon

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	50,101	$0.00	$0.00
Grant/Award	Common Stock	21,105	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 50,101 contracts (Direct); Common Stock — 52,169 shares (Direct)

Footnotes (3)

1. F1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.
2. F2. Includes 24,936 previously reported restricted stock units and 948 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
3. F3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Patrick Fisher report at Orthofix Medical (OFIX)?

Patrick Fisher reported receiving equity awards from Orthofix Medical, including stock options and restricted stock units. On March 3, 2026 he was granted 50,101 employee stock options and 21,105 shares of common stock in the form of restricted stock units at no cash cost.

How many Orthofix Medical stock options were granted to Patrick Fisher?

Patrick Fisher was granted 50,101 employee stock options for Orthofix Medical common stock. These options are a right to buy shares and vest in three equal annual installments on the first, second, and third anniversaries of the March 3, 2026 grant date.

What restricted stock unit grant did Patrick Fisher receive from Orthofix Medical?

Patrick Fisher received 21,105 shares of Orthofix Medical common stock in the form of restricted stock units. The Compensation and Talent Development Committee approved this grant, which vests one-third on each of the first, second, and third anniversaries of the March 3, 2026 grant date.

How do Patrick Fisher’s restricted stock units at Orthofix Medical vest?

Patrick Fisher’s restricted stock units vest over three years in equal installments. One-third of the shares vest on each of the first, second, and third anniversaries of the grant date, aligning his compensation with longer-term Orthofix Medical performance and retention objectives.

What is Patrick Fisher’s Orthofix Medical share ownership after these grants?

After the March 3, 2026 grants, Patrick Fisher directly owns 52,169 Orthofix common shares. This number includes 24,936 previously reported restricted stock units and 948 shares acquired under Orthofix’s Stock Purchase Plan, in addition to the new restricted stock unit award.

What is Orthofix’s Stock Purchase Plan mentioned in Patrick Fisher’s holdings?

Orthofix’s Stock Purchase Plan is described as a “Stock Purchase Plan” under Rule 16b-3(b)(5). Patrick Fisher’s holdings include 948 shares acquired through this plan, and acquisitions under it are exempt from Section 16(b), affecting how insider trading profit recovery rules apply.

Are Patrick Fisher’s new Orthofix stock awards immediate cash purchases?

No, Patrick Fisher’s reported awards are equity grants rather than cash purchases. He received 50,101 options and 21,105 restricted stock units at a stated price of $0.0000 per share, reflecting compensatory awards approved by Orthofix’s Compensation and Talent Development Committee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 06:48 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher Patrick

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TX 75056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Global Limb Recon

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		21,105(1)	A	$0	52,169(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$13.03	03/03/2026		A		50,101		(3)	03/03/2033	Common Stock	50,101	$0	50,101	D

Explanation of Responses:

1. Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.

2. Includes 24,936 previously reported restricted stock units and 948 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

3. The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.

	/s/ J. Andres Cedron, attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.